Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
20/04/2026 15:00
April 20 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST: EXPECTED FINAL DAY OF TRADING ON NASDAQ FIRST NORTH GROWTH MARKET IS 18 MAY Source text: ID:nBQNc3p9GB Further company coverage: LPGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds